CLOSE TIES TO ACADEMIC CENTERS RESEARCH STRUCTURES
The Banook Group has established long-term, strong relationships with well-known academic research centers, such the Institut Gustave Roussy for Cancer Research, and the Pitié-Salpétrière University Teaching Hospital (CHU) for pharmacology. These close partnerships allow us to constantly refine our internal processes and provide high level expertise to our clients.
The privileged relationship we have built with the research teams at these institutions helps us remain at the forefront of advances in all fields, including the most innovative areas of medicine.
Over the 10 last years we have also developed strong relationships with many clinical pharmacology units, mostly in Europe. Through these long-term partnerships we have acquired a deep experience of pharmacology issues and solutions in drug development programs, particularly for cardiac safety in early phase trials (see the key word “IQ QT”).
Acquiring and analyzing clinical data is a technologically complex process. We have collaborated closely with innovative partners that have a deep and broad experience in this field. Our strong ties with these companies have helped us address the most daunting technical challenges raised by our sponsors.
The Banook Group has formed partnerships with the following expert companies:
Aepodia (support in drug developpement),
AMPS (signal processing solutions),
Intrasense (multimodal medical imaging),
Mortara (ECG devices manufacturer),
Phaster 1 (support in early drug development),
PhinC (statistics and PK modeling),
Vangiesbergen (medical writing).
UNIQUE EXPERTISE IN TROPICAL MEDICINE
Our philosophy – People serving Science. Science serving People – could not be better illustrated than by our commitment to research into treatments for tropical diseases, which afflict a substantial portion of people around the world. This area now represents one third of our activity. We work with academic structures specialized in this field, such as the London School of Hygiene and Tropical Medicine and the Liverpool School of Tropical Medicine. We provide services for cardiac safety evaluation in studies sponsored by nonprofit organisations, including the Medicine for Malaria Venture (MMV) and Drug for Neglected Diseases (DNDi).